ID

14189

Description

Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE); ODM derived from: https://clinicaltrials.gov/show/NCT00040378

Lien

https://clinicaltrials.gov/show/NCT00040378

Mots-clés

Versions (1)
  1. 04/04/2016 04/04/2016 -
Téléchargé le

4 avril 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Alzheimer Disease NCT00040378

Anglais

Eligibility Alzheimer Disease NCT00040378

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
participating in select prevention study;
Description

study participation status; prevention study

Type de données

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C1706420
62 years or older if other ethnic origin, or 60 years or older if african-american or hispanic;
Description

age; ethnicity

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0015031
general good health with no neurological or psychiatric illness.
Description

neurological illness; psychiatric illness

Type de données

boolean

Alias
UMLS CUI [1]
C0027765
UMLS CUI [2]
C0004936
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
the select doctors or staff will review the preadvise applicants' medical history and drugs to verify that they have no condition(s) that would exclude them from this study. the participant must not have any of the following neurological conditions based on self report (were told by a physician):
Description

Compliance behavior Limited Comorbidity; neurological conditions

Type de données

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
UMLS CUI [2]
C2359473
alzheimer's disease, or any other form of dementia such as pick's disease, dementia with lewy bodies, frontotemporal dementia, vascular dementia, significant cognitive and motor impairment from a stroke or corticobasal degeneration;
Description

alzheimers disease; dementia; cognitive impairment; stroke; corticobasal degeneration

Type de données

boolean

Alias
UMLS CUI [1]
C0002395
UMLS CUI [2]
C0497327
UMLS CUI [3]
C0009241
UMLS CUI [4]
C0038454
UMLS CUI [5]
C0393570
huntington's disease, epilepsy, parkinson's disease, brain tumor, multiple sclerosis, manic-depressive disorder, or schizophrenia;
Description

huntingtons disease; epilepsy; parkinsons disease; brain tumor; multiple sclerosis; manic-depressive disorder; schizophrenia

Type de données

boolean

Alias
UMLS CUI [1]
C0020179
UMLS CUI [2]
C0014544
UMLS CUI [3]
C0030567
UMLS CUI [4]
C0006118
UMLS CUI [5]
C0026769
UMLS CUI [6]
C1276009
UMLS CUI [7]
C0036341
the participant must not have had a head injury with prolonged loss of consciousness (over 30 minutes) within the past five years;
Description

head injury; Unconscious State

Type de données

boolean

Alias
UMLS CUI [1]
C0018674
UMLS CUI [2]
C0041657
the participant must not have a current alcohol or substance abuse diagnosis, or must have been treatment free for the past 24 months;
Description

substance abuse

Type de données

boolean

Alias
UMLS CUI [1]
C0038586
the participant must not have had a diagnosis of depression or anxiety disorder in the past 4 months and must not currently be under treatment for depression or anxiety disorder. [a participant who was previously diagnosed with depression or anxiety disorder but completed treatment more than four months ago is eligible.];
Description

depression; anxiety disorder

Type de données

boolean

Alias
UMLS CUI [1]
C0011581
UMLS CUI [2]
C0003469
the participant must not currently use of any of the following medications: aricept, cognex, exelon, reminyl, or hydergine;
Description

aricept; cognex; exelon; reminyl; hydergine

Type de données

boolean

Alias
UMLS CUI [1]
C0527315
UMLS CUI [2]
C0699954
UMLS CUI [3]
C0730987
UMLS CUI [4]
C0939465
UMLS CUI [5]
C0591616
the participant must not have blindness, deafness, language difficulties or any other disability that may prevent completion of the memory screen.
Description

blindness; language difficulties

Type de données

boolean

Alias
UMLS CUI [1]
C0564213
Retour au début de la page

Similar models

Eligibility Alzheimer Disease NCT00040378

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
study participation status; prevention study
Item
participating in select prevention study;
boolean
C2348568 (UMLS CUI [1])
C1706420 (UMLS CUI [2])
age; ethnicity
Item
62 years or older if other ethnic origin, or 60 years or older if african-american or hispanic;
boolean
C0001779 (UMLS CUI [1])
C0015031 (UMLS CUI [2])
neurological illness; psychiatric illness
Item
general good health with no neurological or psychiatric illness.
boolean
C0027765 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Compliance behavior Limited Comorbidity; neurological conditions
Item
the select doctors or staff will review the preadvise applicants' medical history and drugs to verify that they have no condition(s) that would exclude them from this study. the participant must not have any of the following neurological conditions based on self report (were told by a physician):
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C2359473 (UMLS CUI [2])
alzheimers disease; dementia; cognitive impairment; stroke; corticobasal degeneration
Item
alzheimer's disease, or any other form of dementia such as pick's disease, dementia with lewy bodies, frontotemporal dementia, vascular dementia, significant cognitive and motor impairment from a stroke or corticobasal degeneration;
boolean
C0002395 (UMLS CUI [1])
C0497327 (UMLS CUI [2])
C0009241 (UMLS CUI [3])
C0038454 (UMLS CUI [4])
C0393570 (UMLS CUI [5])
huntingtons disease; epilepsy; parkinsons disease; brain tumor; multiple sclerosis; manic-depressive disorder; schizophrenia
Item
huntington's disease, epilepsy, parkinson's disease, brain tumor, multiple sclerosis, manic-depressive disorder, or schizophrenia;
boolean
C0020179 (UMLS CUI [1])
C0014544 (UMLS CUI [2])
C0030567 (UMLS CUI [3])
C0006118 (UMLS CUI [4])
C0026769 (UMLS CUI [5])
C1276009 (UMLS CUI [6])
C0036341 (UMLS CUI [7])
head injury; Unconscious State
Item
the participant must not have had a head injury with prolonged loss of consciousness (over 30 minutes) within the past five years;
boolean
C0018674 (UMLS CUI [1])
C0041657 (UMLS CUI [2])
substance abuse
Item
the participant must not have a current alcohol or substance abuse diagnosis, or must have been treatment free for the past 24 months;
boolean
C0038586 (UMLS CUI [1])
depression; anxiety disorder
Item
the participant must not have had a diagnosis of depression or anxiety disorder in the past 4 months and must not currently be under treatment for depression or anxiety disorder. [a participant who was previously diagnosed with depression or anxiety disorder but completed treatment more than four months ago is eligible.];
boolean
C0011581 (UMLS CUI [1])
C0003469 (UMLS CUI [2])
aricept; cognex; exelon; reminyl; hydergine
Item
the participant must not currently use of any of the following medications: aricept, cognex, exelon, reminyl, or hydergine;
boolean
C0527315 (UMLS CUI [1])
C0699954 (UMLS CUI [2])
C0730987 (UMLS CUI [3])
C0939465 (UMLS CUI [4])
C0591616 (UMLS CUI [5])
blindness; language difficulties
Item
the participant must not have blindness, deafness, language difficulties or any other disability that may prevent completion of the memory screen.
boolean
C0564213 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial